Reduced efficacy of treatment of strongyloidiasis in HTLV-I carriers related to enhanced expression of IFN-γ and TGF-β1

Clinical and Experimental Immunology

Volumn 127, Issue 2, 2002, Pages 354-359

  Satoh, M ^a   Toma, H ^b   Sato, Y ^b   Takara, M ^c   Shiroma, Y ^d   Kiyuna, S ^d   Hirayama, K ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF THE RYUKYUS   (Japan)

^c Gushikawa Clinic   (Japan)

^d Izumizaki Hospital   (Japan)

Author keywords

HTLV I; IFN ; Strongyloidiasis; TGF 1; Treatment

Indexed keywords

ALBENDAZOLE; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G4; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY SPECIFICITY; ARTICLE; BACTERIAL IMMUNITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PERSISTENT INFECTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; TREATMENT OUTCOME; VIRUS CARRIER;

AGED; ALBENDAZOLE; ANIMALS; ANTHELMINTICS; ANTIBODIES, HELMINTH; FECES; FEMALE; GENE EXPRESSION REGULATION; HTLV-I INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERFERON TYPE II; INTESTINAL DISEASES, PARASITIC; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; TRANSFORMING GROWTH FACTOR BETA; TREATMENT FAILURE;

EID: 0036130084     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2002.01733.x     Document Type: Article

References (55)

1. Human T-cell leukemia-lymphoma virus type 1 and adult T-cell leukemia-lymphoma in Okinawa
2. Application of enzyme-linked immunosorbent assay for mass examination of strongyloidiasis in Okinawa
3. Antibodies to human T lymphotropic virus type-I in patients with tropic spastic paraparesis
4. HTLV-I-associated myelopathy, a new clinical entity
5. Isolation and characterization of retro-virus from cell lines of human adult T cell leukemia and its implication in the disease
6. Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease
7. High incidence of HTLV antibody in carriers of Strongyloides stercoralis
8. Seven years of recurrent severe strongyloidiasis in an HTLV-I infected man who developed adult T-cell leukaemia
9. Six Colombian patients with adult T-cell leukemia/lymphoma
10. Clinical study of eradicated and resistant patients to treatment with ivermectin for strongyloidiasis
11. Reduced efficacy of chemotherapy might accumulate concurrent HTLV-1 infection among strongyloidiasis patients in Okinawa
12. Immune-dependent chemotherapy of schistosomiasis
13. Strongyloides stercoralis hyperinfection in a carrier of HTLV-I virus with evidence of selective immunosuppression
14. Immunoepidemiologic studies of Strongyloides stercoralis and human T lymphotropic virus type I infections in Jamaica
15. The human interferon-γ gene contains an inducible promoter that can be transactivated by tax I and II
16. Transactivation of the transforming growth factor β1 (TGF-β1) gene by human T lymphotropic virus type 1 Tax: A potential mechanism for the increased production of TGF-β1 in adult T cell leukemia
17. IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons γ and α and prostaglandin E2
18. Modulation of IL-4 induced germline ε RNA synthesis in human B cells by tumor necrosis factor-α, anti-CD40 monoclonal antibodies or transforming growth factor-β correlates with levels of IgE production
19. Regulation of IgE synthesis by cytokines
20. Increased production of interferon γ but not interleukin 4 in human T-lymphotropic virus type I carriers
21. Interferon-γ and interleukin-4 responses in relation to serum IgE levels in persons infected with human T lymphotropic virus type and Strongyloides stercoralis
22. Virus production and spontaneous cell proliferation in HTLV-I-infected lymphocytes
23. A new method to detect Strongyloides stercoralis from human stool
24. Adult T-cell leukemia: Antigen in an ATL cell line and detection of antibodies to the antigen in human sera
25. Prominence of IgG4 antibodies in the human responses to Strongyloides stercoralis infection
26. Fluorometric enzyme-linked immunosorbent assay for the measurement of IgE antibody to mite Dermatophagoides farinae
27. Inhibition of intractable nucleases with ribonucleoside-vanadyl complexes: Isolation of messenger ribonucleic acid from resting lymphocytes
28. Immunologic and virologic characterization of the primary infiltrating cells in the aqueous humor of human T-cell leukemia virus type-1 uveitis
29. Transforming growth factor β1 (TGF-β1) is a preoperative prognostic indicator in advanced gastric carcinoma
30. Human mast cells produce IL-13 by high-affinity IgE receptor cross-linking: Enhanced IL-13 production by IL-4-primed human mast cells
31. Disseminated Strongyloides stercoralis in human immunodeficiency virus-infected patients. Treatment failure and a review of the literature
32. Epstein-Barr virus-specific antibodies in patients with adult T-cell leukemia (ATL) and healthy ATL virus-carriers
33. Suppression of tuberculin skin reaction in healthy HTLV-I carriers from Japan
34. The immune response to nematode parasites: Modulation of mast cell numbers and function during Strongyloides stercoralis infections in nonhuman primates
35. Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium
36. Filarial-specific IgG4 response correlates with active Wuchereria bancrofti infection
37. Monitoring of specific IgG4 antibodies in respiratory allergy due to the pollen of Parietaria judaica. Evidence for a protective role
38. Immunologic changes during immunotherapy in asthmatic children: Increased IL-13 and allergen-specific IgG4 antibody levels
39. Strong serum inhibition of specific IgE correlated to competing IgG4, revealed by a new methodology in subjects from a S. mansoni endemic area
40. IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferon γ and α and prostaglandin E2
41. Regulation of IgE and IgG4 responses by allergen specific T-cell clones to bee venom phospholipase A2 in vitro
42. Induction and differential regulation of bee venom phospholipase A2-specific human IgE and IgG4 antibodies in vitro requires allergen-specific and nonspecific activation of T and B cells
43. Interferon-γ inhibits serotonin release from mouse peritoneal mast cells
44. Nitric oxide inhibits IgE-mediated degranulation of mast cells and is the principal intermediate in IFN-γ-induced suppression of exocytosis
45. Modulation of IL-4 induced jermline ε RNA synthesis in human B cells by tumor necrosis factor-α, anti-CD40 monoclonal antibodies or transforming growth factor-β correlates with levels of IgE production
46. Transforming growth factor-β prevents stem cell factor-mediated rescue of mast cells from apoptosis after IL-3 deprivation
47. TGF-β1 inhibits the release of histamine and tumor necrosis factor-α from mast cells through an autocrine pathway
48. Histopathological changes following primary, secondary and repeated infections of rats with Strongyloides ratti, with special reference to tissue eosinophils
49. The location of antigenic sites on the surface of the nematode parasite Strongyloides ratti reactive to antibody-directed cellular cytotoxicity from both macrophages and eosinophils from the natural host
50. Strongyloides stercoralis: Protective immunity to third-stage larvae in Balb/cByJ mice
51. Long-term therapy with recombinant interferon-gamma (rIFN-γ) for atopic dermatitis
52. Th1-derived cytokine IFN-γ is a potent inhibitor of eotaxin synthesis in vitro
53. Transforming growth factor β abrogates the effects of hematopoietins on eosinophils and induces their apoptosis
54. Mechanism of inhibition of eosinophil activation by transforming growth factor-β
55. Decreased eosinophil numbers in HTLV-I carriers